Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1 2 or 4 weeks

Files
Journal Article.pdf (2.28 MB)
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
WOS
URI
https://hdl.handle.net/10539/40941
Collections
Academic Wits Research Outputs (All submissions)